Informed consent in clinical trials
The development of a new drug is a lengthy process. Once a promising compound is identified, it must be investigated in laboratory studies and tested on laboratory animals. After years of work, the newly developed drug is ready for clinical trials, or the testing on human volunteers.
There are currently no refbacks.